An official website of the United States government
NIH Guide: Weekly Index for October 27, 2023
Weekly NIH Funding Opportunities and Notices
October 27, 2023
Policy Notices
-
Adjustments to NIH Grant Application Due Dates on or Between October 28, 2023 and October 31, 2023
(NOT-OD-24-020)National Institutes of Health
General Notices
-
Notice of Participation of the National Institute on Aging (NIA) in NOT-ES-23-016, "Request for Information (RFI): Environmental Justice Research Gaps, Opportunities and Capacity Building"
(NOT-AG-23-068)National Institute on Aging
-
Notice of Pre-Application Webinar for PAR-23-292: Improving Care and Outcomes for Cancer Survivors from Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional)
(NOT-CA-24-005)National Cancer Institute
-
Notice of Pre-Application Webinar for C06 Research Facilities Construction Grants PAR-23-306 and PAR-24-033
(NOT-OD-24-019)Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
-
Notice of Information to Publish Notice of Special Interest: Developing and Testing Multilevel Physical Activity Interventions to Improve Health and Well-Being
(NOT-OD-24-021)Office of Disease Prevention
-
Request for Information (RFI): NCI Cancer Research Data Commons (CRDC) Artificial Intelligence (AI) use cases to inform an assessment of data readiness
(NOT-CA-24-002)National Cancer Institute
Notice of Changes to Funding Opportunities
-
Notice of Correction to PAR-22-131, Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional)
(NOT-CA-24-004)National Cancer Institute
-
Notice to Extend the Expiration Date of PAR-21-107 NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional)
(NOT-DC-24-007)National Institute on Deafness and Other Communication Disorders
-
Notice of Correction to Information Regarding the Locus of Peer Review for Applications Submitted to PAR-23-213 "Interactive Digital Media (IDM) Biomedical Science Resources for Pre-College Students and Teachers (SBIR)"
(NOT-GM-24-008)National Institute of General Medical Sciences
-
Notice of Change to the Funding Opportunity Award Budget of RFA-OD-24-002, R25 for Short Courses on Techniques for Measuring Intimate Partner Violence (IPV) in Different Populations (R25 Clinical Trial Not Allowed)
(NOT-OD-24-015)Office of Behavioral and Social Sciences Research
-
Notice of Change to Expiration Date for PAR-22-233 Time-Sensitive Opportunities for Health Research (R61/R33 Clinical Trial Not Allowed)
(NOT-OD-24-016)Office of Behavioral and Social Sciences Research
Notices of Intent to Publish
-
Notice of Intent to Publish a Funding Opportunity Announcement for Center of Excellence for Systems Modeling of Infection and Immunity across Biological Scales (U54 Clinical Trial Not Allowed)
(NOT-AI-23-073)National Institute of Allergy and Infectious Diseases
-
Notice of Intent to Publish a Funding Opportunity Announcement for NIDCR Mentoring Network to Support a Diverse Dental, Oral and Craniofacial Research Workforce (UE5 Clinical Trial Not Allowed)
(NOT-DE-24-002)National Institute of Dental and Craniofacial Research
Notices of Special Interest
-
Notice of Special Interest (NOSI): Chemical Countermeasures Research Program (CCRP) Initiative: Additional Research Areas of Interest focusing on Ultra-Potent Synthetic (UPS) Opioids
(NOT-DA-23-044)National Institute on Drug AbuseNational Institute of Allergy and Infectious Diseases
-
Notice of Special Interest (NOSI): Applications of Data Science in Translational Dental, Oral, and Craniofacial Research
(NOT-DE-24-003)National Institute of Dental and Craniofacial Research
-
Notice of special interest (NOSI): Adopting Techniques and Tools Developed from the BRAIN Initiative Toward NIMH Strategic Research Priorities
(NOT-MH-24-290)National Institute of Mental Health
-
Notice of Special Interest (NOSI): Administrative Supplements to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) Mentorship
(NOT-OD-24-001)Office of the Director, NIHNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute of Allergy and Infectious DiseasesNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute of General Medical SciencesNational Cancer InstituteNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Institute of Dental and Craniofacial ResearchNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Environmental Health SciencesNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Human Genome Research InstituteNational Heart, Lung, and Blood InstituteNational Library of MedicineNational Institute of Mental HealthNational Institute of Nursing ResearchNational Center for Advancing Translational SciencesNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringNational Institute on Minority Health and Health DisparitiesNational Center for Advancing Translational Sciences
Funding Opportunities
-
Advancing Hearing and Balance Research Using Auditory and Vestibular Organoids (R21-Clinical Trial Not Allowed)
(PAS-24-057)National Institute on Deafness and Other Communication DisordersApplication Receipt Date(s): May 7, 2024
-
Advancing Hearing and Balance Research Using Auditory and Vestibular Organoids (R01-Clinical Trial Not Allowed)
(PAS-24-058)National Institute on Deafness and Other Communication DisordersApplication Receipt Date(s): May 7, 2024
-
Development of Candidate Radiation/Nuclear Medical Countermeasures (MCMs) (U01 Clinical Trial Not Allowed)
(RFA-AI-23-059)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): January 26, 2024
-
Engineering and Preclinical Development of Biological Products that Eliminate HIV-infected Cells (UG3/UH3 Clinical Trial Not Allowed)
(RFA-AI-23-060)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): March 13, 2024
-
Long-Acting Drug Delivery Systems for ART Optimization in Children Living with HIV-1 II (LADDS II) (R61/R33 Clinical Trial Not Allowed)
(RFA-AI-23-061)National Institute of Allergy and Infectious DiseasesEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental HealthApplication Receipt Date(s): March 13, 2024
-
Resource Center for Cannabis and Cannabinoid Research (U24 Clinical Trial Not Allowed)
(RFA-AT-24-006)National Center for Complementary and Integrative HealthNational Institute on AgingNational Cancer InstituteNational Institute on Drug AbuseApplication Receipt Date(s): April 16, 2024
-
Tools for Decentralized Clinical Trials for Substance Use Disorder (R41/R42 Clinical Trials Optional)
(RFA-DA-25-051)National Institute on Drug AbuseApplication Receipt Date(s): March 14, 2024
-
Tools for decentralized clinical trials for substance use disorder (R43/R44 Clinical Trials Optional)
(RFA-DA-25-052)National Institute on Drug AbuseApplication Receipt Date(s): March 14, 2024
-
Single Source for continuation of the Human Pancreas Analysis Program for Type-2 Diabetes (HPAP-T2D) (U01 Clinical Trial Not Allowed)
(RFA-DK-25-002)National Institute of Diabetes and Digestive and Kidney DiseasesApplication Receipt Date(s): February 28, 2024
NIH Funding Opportunities are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
This page last updated on: December 10, 2024
For technical issues E-mail OER Webmaster